Completed Projects
| No. | Project Title | Funder | Principal Investigator |
| 1 | A Glucose-6-Phosphate Dehydrogenase (G6PD) Enzyme Assay Validation Protocol (GSK1126) | GlaxoSmithKline (GSK) | Prof. Daniel Yilma |
| 2 | A Randomized Double-Blind, Double-Dummy Comparative Multicenter Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine versus Primaquine in the Treatment of Subjects with Plasmodium vivax Malaria (TAF116564) | GlaxoSmithKline (GSK) | Prof. Daniel Yilma |
| 3 | Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria (TAF112582) | GlaxoSmithKline (GSK) | Prof. Daniel Yilma |
| 4 | Validation of Diagnostics to Identify G6PD Deficiency in Western Ethiopia (PATH) | PATH | Prof. Daniel Yilma |
| 5 | Capacity Building for Agaro and Jimma University Clinical Trial Unit | Medicines for Malaria Venture (MMV) | Prof. Daniel Yilma |
| 6 | An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of a Single Dose of MMV390048 in Adult Patients with Acute, Uncomplicated Plasmodium vivax or Plasmodium falciparum Malaria Mono-infection over a 35-Day Period (MMV390048) | Medicines for Malaria Venture (MMV) | Prof. Daniel Yilma |
| 7 | Are Kidney Function and Kidney Size Associated with Low Birth Weight and Stunting in Ethiopian Children? (LABC Kidney) | GlaxoSmithKline (GSK) | Prof. Daniel Yilma |
| 8 | Comprehensive Multicenter Bioinformatics-Based Action to Tackle AMR in Sub-Saharan Africa at Jimma University Medical Center (ESTHER/COMBAT-AMR) | German Agency for International Cooperation (GIZ) | Prof. Esayas Kebede Gudina |
| 9 | Prevalence, Incidence, and Dynamics of SARS-CoV-2 Specific Antibodies among Frontline Healthcare Workers and Communities in Jimma and Addis Ababa, Ethiopia (JU-LMU-COVID-19) | Bavarian State Ministry for Science and Art (STMWK) | Prof. Esayas Kebede Gudina |
| 10 | COVSERO (COMBAT-AMR Network) | German Agency for International Cooperation (GIZ) | Prof. Esayas Kebede Gudina |